Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status

Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Wei J. et al, (2022), Nature Medicine

Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins.

Smilova MD. et al, (2022), Journal of chemical information and modeling, 62, 284 - 294

Target 2035-update on the quest for a probe for every protein

Mueller S. et al, (2021), RSC MEDICINAL CHEMISTRY

Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections

Eyre DW. et al, (2021), BMC Infectious Diseases, 21

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom

Vihta K-D. et al, (2021), Clinical Infectious Diseases

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

Wei J. et al, (2021), Nature Microbiology, 6, 1140 - 1149

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Lumley SF. et al, (2021), Clinical Infectious Diseases, 73, e699 - e709

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei J. et al, (2021)

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei J. et al, (2021)

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Wei J. et al, (2021)

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Lumley SF. et al, (2021), New England Journal of Medicine, 384, 533 - 540

High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging

Chen J. et al, (2021), Science Advances, 7

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

Pouwels KB. et al, (2021), The Lancet Public Health, 6, e30 - e38

Decreased blood vessel density and endothelial cell subset dynamics during ageing of the endocrine system.

Chen J. et al, (2021), The EMBO journal, 40

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400

SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020

Lumley SF. et al, (2020), Eurosurveillance, 25

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

Eyre DW. et al, (2020), eLife, 9

Load More

1
2
3
4
5

Include forthcoming?